Physician

Alessia Carluccio Roehnelt, MD

According to 2025 Medicare claims, Alessia Roehnelt, MD (NPI: 1841599651) practices endocrinology in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07042-3318. Roehnelt is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Roehnelt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 718 traditional Medicare patients, billed 4,785 HCPCS/CPT codes, and received $163,784 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,373 prescription claims across 449 beneficiaries totaling $1,634,525 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 205 claims. Open Payments data shows 2 records totaling $140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $7,161 to $163,784. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,218 to $1,634,525. For DME billing, reported payments moved sharply higher in recent years, from $249 to $53,581.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	37	84	$7,161
2016	N/R	N/R	N/R
2017	67	309	$17,601
2018	207	1,748	$66,749
2019	187	1,813	$53,421
2020	215	3,254	$81,857
2021	273	4,754	$126,890
2022	335	6,131	$150,078
2023	392	5,751	$145,555
2024	718	4,785	$163,784

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	73	$4,218
2016	39	204	$46,259
2017	91	416	$67,475
2018	189	1,589	$477,878
2019	216	1,716	$594,837
2020	248	1,910	$774,422
2021	291	2,490	$1,024,742
2022	362	2,876	$1,431,670
2023	417	3,242	$1,762,304
2024	449	3,373	$1,634,525

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	37	72	$2,923
2019	36	128	$11,967
2020	33	121	$13,195
2021	35	148	$14,490
2022	60	215	$26,268
2023	61	245	$34,276
2024	64	205	$52,207

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	331	451	$102
76536	Ultrasound scan of head and neck soft tissue	337	339	$95
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	332	430	$14
80053	Blood test, comprehensive group of blood chemicals	119	138	$10
36415	Insertion of needle into vein for collection of blood sample	154	198	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	332	12,280	$434,259
Ozempic	Semaglutide	156	7,800	$246,946
Jardiance	Empagliflozin	148	10,070	$193,031
Teriparatide	Teriparatide	69	2,228	$189,925
Trulicity	Dulaglutide	39	2,002	$65,572

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	30	122	$50,664
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	22	56	$1,482
A4259	Lancets, per box of 100	N	12	27	$60

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$140	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alessia Carluccio Roehnelt, MD?

Tedicare shows public-source Medicare data for Alessia Carluccio Roehnelt, MD (NPI 1841599651), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alessia Carluccio Roehnelt, MD have ACO affiliation data?

Alessia Carluccio Roehnelt, MD is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Alessia Carluccio Roehnelt, MD?

Alessia Carluccio Roehnelt, MD is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Alessia Carluccio Roehnelt, MD have Open Payments data?

Alessia Carluccio Roehnelt, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.